SANDU PHARMACEUTICALS LTD. (SANDUPHQ) reported revenue of ₹16.39 Cr and net profit of ₹22.82 L for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
SANDUPHQ fundamentals, Fundamental score 31/100
The statements below are read from SANDU PHARMACEUTICALS LTD.’s filed results, 6 filed quarters and 12 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 11, 2026
Sales CAGR · 3Y+2.3%FY22 → FY25
Sales CAGR · 4Y+1.7%FY21 → FY25
PAT CAGR · 3Y+5.1%FY22 → FY25
PAT CAGR · 4Y+2.7%FY21 → FY25
Price · 1Y—EOD
Price CAGR · 3Y—EOD
Showing standalone — consolidated filings end Q4 FY24-25.
Quarterly resultsStandalone
₹ Cr
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
14.1
16.7
17.6
18.8
16.9
16.4
-1.9%
13.6
16.2
16.8
17.7
16.3
15.9
-2.0%
Operating profit
0.45
0.53
0.86
1.04
0.57
0.54
+2.2%
OPM %
3.2%
3.1%
4.9%
5.5%
3.4%
3.3%
+0.1 pp
Other income
0.07
0.02
0.05
0.01
0.37
0.02
-1.7%
Interest
0.03
0.03
0.03
0.03
0.03
0.03
+13.3%
Depreciation
0.15
0.18
0.17
0.17
0.16
0.16
-7.8%
Profit before tax
0.34
0.34
0.71
0.86
0.75
0.36
+6.4%
Tax %
4.7%
34.1%
26.6%
-14.0%
94.2%
36.7%
+2.6 pp
Net profit
0.33
0.22
0.52
0.98
0.04
0.23
+2.2%
EPS (₹)
0.34
0.23
0.54
1.01
0.04
0.37
+60.9%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 6 quarters
RevenueNet profit
Revenue & net profit — Standalone6 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±2.3%· EPS surprise: no estimates source· 3 earlier quarters have no dated filing on record
Q1'27filed Tue 11 Aug 17:46 · first tradeable session Wed 12 Auggap +1.0%close −0.4%
Q4'26filed Tue 5 May 18:31 · first tradeable session Wed 6 Maygap +4.5%close −0.5%
Q3'26filed Fri 6 Feb 17:51 · first tradeable session Mon 9 Febgap +3.5%close +6.0%
